The company would seek approval from its shareholders through a postal ballot for the same, it said in a filing to the BSE.
"It has proposed to enhance its borrowing limit from Rs 5,000 crore to Rs 10,000 crore," the filing said.
Last week, Torrent Pharmaceuticals said it plans to raise up to Rs 10,000 crore by issuing securities and will seek shareholders' nod in this regard.
The Ahmedabad-based firm plans to allot "equity shares including convertible bonds/debentures through Qualified Institutional Placement ( QIP) and/or depository receipts or any other modes for an amount not exceeding Rs 3,000 crore."
Both the fund raising plans would be "subject to the overall borrowing limits of Rs 10,000 crore as proposed".
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
